Can Equipoise Replace Primobolan During Shortages? (TRT Q&As)
Timeline
Equipoise can be a powerful muscle-building androgen, but Dr. O’Connor emphasizes that it can also substantially increase red blood cell production and erythrocytosis risk.
Dr. O’Connor does not automatically recommend stopping TRT but stresses individualized assessment of venous thromboembolism risk and appropriate postoperative clot prevention with the surgical and medical team.
Dr. O’Connor explains that Proviron should not be viewed as a systemic aromatase inhibitor and believes its anti-estrogenic effects are more likely occurring at specific tissues rather than substantially lowering circulating estradiol.
Testosterone can worsen anxiety or other psychiatric symptoms in a susceptible minority of men, and Dr. O’Connor recommends reassessing the original indication, dose, mental health history, and individual response rather than using a cookie-cutter TRT approach.
Dr. O’Connor says the two esters have similar pharmacokinetics and recommends choosing a practical schedule, maintaining it long enough to reach steady state, and judging the response from symptoms and properly timed laboratory testing.
An eGFR below 60 deserves further evaluation before assuming true kidney disease because muscle mass and creatine can affect creatinine-based estimates, and Dr. O’Connor recommends confirming kidney function before adding more androgen exposure.
Video Summary
This Q&A opens with whether Equipoise can substitute for Primobolan when supply shortages limit access. Dr. O’Connor explains that Equipoise can be a powerful muscle-building androgen but also strongly stimulates red blood cell production, making erythrocytosis and broader cardiovascular risk important concerns.
The discussion moves through several testosterone and anabolic-steroid questions, including whether TRT should be stopped before major joint replacement surgery, the risk of DVT and pulmonary embolism, whether Proviron can control estrogen, and how testosterone, Equipoise, Trenbolone, Primobolan, and Masteron differ in their effects.
Later questions address panic and anxiety after TRT, switching between testosterone cypionate and enanthate, injection frequency, low SHBG, and whether additional Primobolan is appropriate when estimated kidney function is reduced. Throughout the Q&A, Dr. O’Connor repeatedly emphasizes individualized assessment, blood pressure, cardiovascular and kidney health, laboratory interpretation, and avoiding unnecessary androgen exposure.
Drug Callouts
Condition Callouts
Key Takeaways
- Equipoise may substitute for Primobolan in some steroid regimens, but its strong effect on red blood cell production increases health concerns.
- Men on TRT undergoing major orthopedic surgery need individualized clot-risk assessment rather than automatically stopping testosterone or self-prescribing anticoagulants.
- Proviron should not be treated as a systemic aromatase inhibitor because its anti-estrogenic effects appear to differ from drugs that directly block aromatase.
- Testosterone can worsen anxiety or panic symptoms in susceptible men, making psychiatric history and individual response important parts of TRT management.
- Testosterone cypionate and enanthate have similar long-acting pharmacokinetics, so injection frequency should be practical, consistent, and evaluated after steady state.
- Reduced estimated kidney function should be confirmed carefully before adding Primobolan or other anabolic steroids to an existing testosterone regimen.